Press Coverage

3 Questions to Mauna Kea Technologies

11 October 2023

Sacha Loiseau, CEO of Mauna Kea Technologies, discusses the 2023 half-year results and the Company's outlook in 3 questions. (Presented in French language with English subtitles.)

Latest News

Mauna Kea Technologies Announces Publication of a Landmark Systematic Review and Meta-Analysis Reinforcing the Diagnostic Accuracy and Clinical Impact of Cellvizio in Upper Gastrointestinal Cancer 

Mauna Kea Technologies Announces Publication of a Landmark Systematic Review and Meta-Analysis Reinforcing the Diagnostic Accuracy and Clinical Impact of Cellvizio in Upper Gastrointestinal Cancer 

Mauna Kea Technologies Announces Two New Peer-Reviewed Clinical Studies Confirming the Clinical Value of Cellvizio® and Its Combination with AI for the Diagnosis of Pancreatic Cysts 

Mauna Kea Technologies Announces Two New Peer-Reviewed Clinical Studies Confirming the Clinical Value of Cellvizio® and Its Combination with AI for the Diagnosis of Pancreatic Cysts 

Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth 

Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth 

No results found.